Pacific Biosciences Of Stock Gross Profit

PACB Stock  USD 1.63  0.07  4.49%   
Pacific Biosciences of fundamentals help investors to digest information that contributes to Pacific Biosciences' financial success or failures. It also enables traders to predict the movement of Pacific Stock. The fundamental analysis module provides a way to measure Pacific Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pacific Biosciences stock.
Last ReportedProjected for Next Year
Gross Profit37.3 M28.8 M
Gross Profit Margin 0.24  0.28 
The current year's Gross Profit Margin is expected to grow to 0.28, whereas Gross Profit is forecasted to decline to about 28.8 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Pacific Biosciences of Company Gross Profit Analysis

Pacific Biosciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

 = 

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Pacific Biosciences Gross Profit

    
  47.67 M  
Most of Pacific Biosciences' fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pacific Biosciences of is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Pacific Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Pacific Biosciences is extremely important. It helps to project a fair market value of Pacific Stock properly, considering its historical fundamentals such as Gross Profit. Since Pacific Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pacific Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pacific Biosciences' interrelated accounts and indicators.
0.980.730.95-0.840.860.990.990.980.350.960.920.88-0.27-0.830.820.230.86-0.90.940.930.9
0.980.690.9-0.860.850.990.940.970.30.950.940.91-0.25-0.750.830.240.84-0.920.930.910.9
0.730.690.59-0.60.490.750.740.80.40.640.650.45-0.23-0.590.570.320.74-0.630.490.860.59
0.950.90.59-0.840.920.890.950.880.360.940.790.88-0.22-0.940.720.230.77-0.770.950.80.87
-0.84-0.86-0.6-0.84-0.89-0.82-0.81-0.79-0.58-0.9-0.83-0.910.320.81-0.84-0.4-0.860.79-0.85-0.76-0.85
0.860.850.490.92-0.890.80.850.780.520.930.750.94-0.43-0.860.740.210.75-0.690.90.70.81
0.990.990.750.89-0.820.80.960.990.310.930.950.86-0.26-0.740.820.260.85-0.940.910.950.89
0.990.940.740.95-0.810.850.960.970.380.950.880.84-0.27-0.860.790.230.84-0.870.910.920.88
0.980.970.80.88-0.790.780.990.970.330.920.920.82-0.27-0.740.810.230.86-0.910.870.970.86
0.350.30.40.36-0.580.520.310.380.330.420.360.41-0.48-0.440.570.250.53-0.280.270.370.35
0.960.950.640.94-0.90.930.930.950.920.420.880.92-0.32-0.840.830.270.86-0.850.920.870.88
0.920.940.650.79-0.830.750.950.880.920.360.880.87-0.29-0.630.890.270.85-0.980.880.880.89
0.880.910.450.88-0.910.940.860.840.820.410.920.87-0.35-0.760.850.250.78-0.820.950.730.88
-0.27-0.25-0.23-0.220.32-0.43-0.26-0.27-0.27-0.48-0.32-0.29-0.350.14-0.330.13-0.350.24-0.25-0.26-0.26
-0.83-0.75-0.59-0.940.81-0.86-0.74-0.86-0.74-0.44-0.84-0.63-0.760.14-0.6-0.28-0.690.61-0.83-0.69-0.77
0.820.830.570.72-0.840.740.820.790.810.570.830.890.85-0.33-0.60.310.82-0.860.780.770.8
0.230.240.320.23-0.40.210.260.230.230.250.270.270.250.13-0.280.310.32-0.310.220.260.27
0.860.840.740.77-0.860.750.850.840.860.530.860.850.78-0.35-0.690.820.32-0.830.760.920.92
-0.9-0.92-0.63-0.770.79-0.69-0.94-0.87-0.91-0.28-0.85-0.98-0.820.240.61-0.86-0.31-0.83-0.86-0.88-0.89
0.940.930.490.95-0.850.90.910.910.870.270.920.880.95-0.25-0.830.780.220.76-0.860.780.92
0.930.910.860.8-0.760.70.950.920.970.370.870.880.73-0.26-0.690.770.260.92-0.880.780.86
0.90.90.590.87-0.850.810.890.880.860.350.880.890.88-0.26-0.770.80.270.92-0.890.920.86
Click cells to compare fundamentals

Pacific Gross Profit Historical Pattern

Today, most investors in Pacific Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pacific Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's gross profit growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Pacific Biosciences gross profit as a starting point in their analysis.
   Pacific Biosciences Gross Profit   
53.5M44.2M34.7M25.1M34.6M32.6M58.9M49.0M52.8M37.3M28.8M100%
       Timeline  
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
Competition

According to the company disclosure, Pacific Biosciences of reported 47.67 M of gross profit. This is 97.87% lower than that of the Life Sciences Tools & Services sector and 97.04% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.83% higher than that of the company.

Pacific Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pacific Biosciences' direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pacific Biosciences could also be used in its relative valuation, which is a method of valuing Pacific Biosciences by comparing valuation metrics of similar companies.
100%
Pacific Biosciences is currently under evaluation in gross profit category among its peers.

Pacific Fundamentals

Return On Equity-0.51
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-400%-300%-200%-100%
Return On Asset-0.12
Profit Margin(2.00) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Operating Margin(1.62) %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Current Valuation762.24 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-7,000%-6,000%-5,000%-4,000%-3,000%-2,000%-1,000%
Shares Outstanding294.32 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%1,000%
Shares Owned By Insiders9.30 %
Shares Owned By Institutions84.98 %
Number Of Shares Shorted60.4 M
Price To Earning197.88 X
Price To Book0.94 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-10,000%-8,000%-6,000%-4,000%-2,000%
Price To Sales3.11 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Revenue154.01 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312,000%4,000%6,000%8,000%
Gross Profit47.67 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%2,000%2,500%
EBITDA(356.38 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%
Net Income(306.74 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%
Cash And Equivalents834.34 M
Cash Per Share3.69 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Total Debt933.93 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-3120,000%40,000%60,000%80,000%
Debt To Equity1.51 %
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-12,000%-10,000%-8,000%-6,000%-4,000%-2,000%
Current Ratio11.19 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-80%-60%-40%-20%
Book Value Per Share1.79 X
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31-100%-80%-60%-40%-20%
Cash Flow From Operations(259.17 M)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%500%1,000%1,500%
Short Ratio5.81 X
Earnings Per Share(1.65) X
Price To Earnings To Growth(0.17) X
Target Price2.67
Beta1.92
Market Capitalization479.73 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31200%400%600%800%
Total Asset1.75 B
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Retained Earnings(1.84 B)
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%
Working Capital647.02 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31
Current Asset110.54 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-310%200%400%600%800%
Current Liabilities38.18 M
JavaScript chart by amCharts 3.21.152011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-31500%1,000%1,500%2,000%
Net Asset1.75 B

About Pacific Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Pacific Biosciences of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pacific Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pacific Biosciences of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:
Check out Pacific Biosciences Piotroski F Score and Pacific Biosciences Altman Z Score analysis.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.65)
Revenue Per Share
0.561
Quarterly Revenue Growth
(0.33)
Return On Assets
(0.12)
Return On Equity
(0.51)
The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.


 
News Freq…Investor S…